A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus

被引：1
作者：
Sachdeva P. [1 ]
Ashrit R.M. [1 ]
Shukla R. [1 ]
Sahani A. [1 ]
机构：
[1] Department of Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar
来源：
Journal of Medical Engineering and Technology | 2022年 / 46卷 / 08期
关键词：
artificial pancreas; bionic pancreas; continuous glucose monitoring; Diabetes; diabetes management; glucose sensor; insulin delivery; regenerative tissue;
D O I：
10.1080/03091902.2022.2095049
中图分类号：
学科分类号：
摘要：
Diabetes mellitus is one of the fastest-growing lifestyle disorders in the world. While numerous regimes have been developed to manage diabetes, there continue to be high numbers of diabetes-related deaths worldwide. The review gives a brief introduction to the pathology and aetiology of the disorder, different solutions developed over time with their advantages and disadvantages, and highlights the technological components and challenges of the latest technologies: artificial pancreas and regenerative medicine. The study is restricted to a set of high-quality publications from the last decade. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
引用
收藏
页码：693 / 702
页数：9
相关论文
共 70 条
[1]  
Mobasseri M., Shirmohammadi M., Amiri T., Et al., Prevalence and incidence of type 1 diabetes in the world: a systematic review and Meta-analysis, Health Promot Perspect, 10, 2, pp. 98-115, (2020)
[2]  
Moini J., (2019)
[3]  
Wagner D., Type 1 diabetes: pathogenesis, genetics and immunotherapy, (2011)
[4]  
Katsarou A., Gudbjornsdottir S., Rawshani A., Et al., Type 1 diabetes mellitus, Nat Rev Dis Primers, 3, (2017)
[5]  
Powers A.C., Type 1 diabetes mellitus: much progress, many opportunities, J Clin Invest, 131, 8, (2021)
[6]  
Roche E.F., Menon A., Gill D., Et al., Clinical presentation of type 1 diabetes, Pediatr Diabetes, 6, 2, pp. 75-78, (2005)
[7]  
Melendez-Ramirez L.Y., Yvonne Melendez-Ramirez L., Richards R.J., Et al., Complications of type 1 diabetes, Endocrinol Metab Clin North Am, 39, 3, pp. 625-640, (2010)
[8]  
Papatheodorou K., Papanas N., Banach M., Et al., Complications of diabetes 2016, J Diabet Res, 2016, pp. 1-3, (2016)
[9]  
de Ferranti S.D., de Boer I.H., Fonseca V., Et al., Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American heart association and American diabetes association, Diabetes Care, 37, 10, pp. 2843-2863, (2014)
[10]  
Ramchandani N., Heptulla R.A., New technologies for diabetes: a review of the present and the future, Int J Pediatr Endocrinol, 2012, 1, (2012)
1234567